Set up FreeStyle Libre 3 Plus
FreeStyle Libre Customer Care Team: If you require further assistance to set up your sensor for the first time, check out more self‑help materials available on the Abbott Support page or call (855) 632-8658.
Download the mobile app
Start sensor
Note: When you begin pump therapy, you will no longer use the FreeStyle Libre 3 app. The Tandem t:slim mobile app will be used for sensor start.
Get familiar with your new sensor using the FreeStyle Libre App.
At training, you will use the Tandem t:slim mobile app to pair your sensor with your pump. Please have a new sensor for pump start.
Estimated Duration: 1 min.
Quick Start Guide
Download the mobile app
Start sensor
Note: When you begin pump therapy, you will no longer use the FreeStyle Libre 3 app. The Tandem t:slim mobile app will be used for sensor start.
Get Started with the FreeStyle Libre App
Get familiar with your new sensor using the FreeStyle Libre App.
At training, you will use the Tandem t:slim mobile app to pair your sensor with your pump. Please have a new sensor for pump start.
Important Safety Information
RX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog, Humalog, or Lyumjev U-100 insulin.
t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or https://www.freestyle.abbott/us-en/safety-information.html for safety info.